Top Markets
#1 Cortex Cortex +173.85%
#2 GEKKO GEKKO +52.86%
#3 Audiera Audiera +20.07%
#4 ADO Protocol ADO Protocol +17.27%
#5 Seeker Seeker +16.11%
#6 o1.exchange o1.exchange +12.87%
#7 Status Status +9.82%
#8 OpenGradient OpenGradient +9.53%
#9 Pons Pons +9.24%
#10 Helium Helium +8.90%
Coin of the day
Cortex Cortex
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Sopharma AD Sopharma AD

Sopharma AD

SPH
Classifica tra le azioni #8637
Sopharma AD, an international pharmaceutical company founded in Sofia,... Sopharma AD, an international pharmaceutical company founded in Sofia, Bulgaria, in 1933, specializes in the research, development, manufacturing, and commercialization of a wide array of healthcare products. Its offerings span medicinal substances, finished drug formulations, veterinary vaccines, infusion solutions, and disposable plastic medical devices for both human and animal health, in addition to food supplements. The company's diverse product portfolio addresses numerous therapeutic categories, including cardiology, gastroenterology, pain management, cough and cold remedies, immunology and dermatology, respiratory conditions (like asthma), neurology and psychiatry, urology, and gynecology. Key products include Carsil for gastrointestinal issues, the analgesic Tempalgin, Tabex for smoking cessation, Tribestan to support sexual system functions, Broncholytin for coughs, the common pain reliever Analgin, Nivalin for peripheral nervous system disorders, and Methylprednisolon for severe allergies and critical medical situations. Beyond its core pharmaceutical business, Sopharma AD engages in a variety of other ventures. These include providing secondary packaging services for pharmaceuticals, leasing real estate, and operating in the retail sector for medicines and medical equipment. The company also handles the cultivation, collection, and trade of herbs and medicinal plants. Furthermore, it is involved in the trading, transport, and packaging of radioactive materials and nuclear equipment for medical applications, as well as household electronics and electrical equipment. Sopharma AD also offers market and public opinion research, provides franchising and know-how, and participates in various consulting and non-pharmaceutical activities, such as the production of veterinary vaccines and infusion solutions.
Prezzo delle azioni
$2.28
Ultima sincronizzazione: 2026-08-27
Capitalizzazione di mercato
$1.20B
Variazione (1 giorno)
2.53%
Variazione (1 anno)
-34.74%
Paese
BG
Scambia Sopharma AD (SPH)

Categoria

Healthcare
EPS per Sopharma AD (SPH)
EPS al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Sopharma AD, l’EPS attuale della società (TTM) è 0. Alla fine del 2026, la società aveva un EPS di 0 uguale a rispetto a quello del 2026, che era di 0.
Storico EPS per Sopharma AD da 2026 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
Non abbastanza dati per le date fornite.
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
McKesson Corporation McKesson Corporation
McKesson Corporation
MCK.US
 $37.53 -
US
Cencora, Inc. Cencora, Inc.
Cencora, Inc.
COR.US
 - -
US
Cardinal Health, Inc. Cardinal Health, Inc.
Cardinal Health, Inc.
CAH.US
 $7.27 -
US
AmerisourceBergen Corporation AmerisourceBergen Corporation
AmerisourceBergen Corporation
ABC.US
 - -
US
Sigma Healthcare Limited Sigma Healthcare Limited
Sigma Healthcare Limited
SIG.AX
 $0.04 -
AU